| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |